Biomedical Service Center is categorized under Services (Unclassified) in Corpus Christi, TX and active since 2011.
Biomedical Service Center was established in 2011, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Services (Unclassified) business, which does work in the B2B market, and is classified as a Services (Unclassified), under code number 541990 by the NAICS.
If you are seeking more information, feel free to contact Jaime Arevalo at the company’s single location by writing to 555 South Shoreline Boulevard # 101, Corpus Christi, Texas TX 78401 or by phoning (361) 510-2894. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Biomedical Service Center |
| Contact Person: | Jaime Arevalo |
| Address: | 555 South Shoreline Boulevard # 101, Corpus Christi, Texas 78401 |
| Phone Number: | (361) 510-2894 |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Services (Unclassified) |
| SIC Code: | 8999 |
| NAICS Code: | 541990 |
| Share This Business: |
Biomedical Service Center was started in 2011 to provide professional Services (Unclassified) under the SIC code 8999 and NAICS code 541990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Jaime Arevalo for inquiries that concern Biomedical Service Center by calling the company number (361) 510-2894, as your correspondence is most welcome. Additionally, the physical location of the single location of Biomedical Service Center can be found at the coordinates 27.786993,-97.394826 as well as the street address 555 South Shoreline Boulevard # 101 in Corpus Christi, Texas 78401.
For its online presence, you may visit Biomedical Service Center’s website at and engage with its social media outlets through on Twitter and on Facebook.